5 Leukemia Clinical Trials in Madera, CA (2026)

Q: How do I join a clinical trial in Madera?

Browse available studies, click one that interests you, and complete the free eligibility form. A study coordinator at the Madera research site will contact you.

Recruiting Leukemia Studies in Madera

NCT07022678Recruiting

Xylitol Dental Wipes for the Reduction of Bloodstream Infection Risk in Children With Acute Myeloid Leukemia

This phase III trial compares the effect of xylitol dental wipes to dental wipes without xylitol for the reduction of bloodstream infection in children with acute myeloid leukemia (AML). Xylitol is a ...

Madera, CAPHASE3556 participantsChildren's Oncology Group

View Study Details

NCT05702645Recruiting

A Study to Learn More About the Health of Persons With Down Syndrome After Treatment for Acute Leukemia

This study attempts to learn more about the health of persons with Down syndrome after treatment for acute leukemia. Children with Down syndrome are at increased risk for side effects during treatment...

Madera, CA330 participantsChildren's Oncology Group

View Study Details

NCT06124157Recruiting

A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)

This pilot trial assesses the effect of the combination of blinatumomab with dasatinib or imatinib and standard chemotherapy for treating patients with Philadelphia chromosome positive (Ph+) or ABL-cl...

Madera, CAPHASE2222 participantsNational Cancer Institute (NCI)

View Study Details

NCT05848687Recruiting

TINI 2: Total Therapy for Infants With Acute Lymphoblastic Leukemia II

The purpose of this study is to improve upon the TINI study treatment. The study will test the ability of a type of immunotherapy called blinatumomab to clear persistent leukemia. Blinatumomab targets...

Madera, CAPHASE190 participantsTanja Andrea Gruber

View Study Details

NCT06900595Recruiting

Testing the Addition of an Anti-Cancer Drug, Cabozantinib to the Immunotherapy Drug Cemiplimab (REGN2810), in Adolescents and Adults With Advanced Adrenocortical Cancer

This phase II trial compares the effect of giving cabozantinib with or without cemiplimab in patients with adrenocortical cancer that has spread to nearby tissue or lymph nodes (locally advanced), and...

Madera, CAPHASE248 participantsNational Cancer Institute (NCI)

View Study Details

About Leukemia Clinical Trials in Madera

Leukemia is a group of blood cancers that develop in the bone marrow and result in abnormal white blood cells. Types include acute myeloid (AML), acute lymphoblastic (ALL), chronic myeloid (CML), and chronic lymphocytic (CLL). Treatment varies by type and may include chemotherapy, targeted therapy, and stem cell transplant.

There are currently 5 leukemia clinical trials recruiting participants in Madera, CA. These studies are seeking a combined 1,246 participants. Research is being sponsored by Children's Oncology Group, National Cancer Institute (NCI), Tanja Andrea Gruber. Clinical trial participation is free and participants receive study-related medical care at no cost.

Leukemia Clinical Trials in Madera — FAQ

Are there leukemia clinical trials in Madera?

Yes, there are 5 leukemia clinical trials currently recruiting in Madera, CA. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Madera?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Madera research site will contact you about next steps.

Are clinical trials in Madera free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Madera studies also compensate for your time and travel.

What leukemia treatments are being tested?

The 5 active trials in Madera are testing new therapies including novel drugs, biologics, and treatment approaches for leukemia.

Data updated July 22, 2026 from ClinicalTrials.gov